Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England

Epidemiology and infection, 145(1), 208-215

DOI 10.1017/S0950268816002065 PMID 27678278 Source

Abstract

Pelvic inflammatory disease (PID) and more specifically salpingitis (visually confirmed inflammation) is the primary cause of tubal factor infertility and is an important risk factor for ectopic pregnancy. The risk of these outcomes increases following repeated episodes of PID. We developed a homogenous discrete-time Markov model for the distribution of PID history in the UK. We used a Bayesian framework to fully propagate parameter uncertainty into the model outputs. We estimated the model parameters from routine data, prospective studies, and other sources. We estimated that for women aged 35-44 years, 33·6% and 16·1% have experienced at least one episode of PID and salpingitis, respectively (diagnosed or not) and 10·7% have experienced one salpingitis and no further PID episodes, 3·7% one salpingitis and one further PID episode, and 1·7% one salpingitis and ⩾2 further PID episodes. Results are consistent with numerous external data sources, but not all. Studies of the proportion of PID that is diagnosed, and the proportion of PIDs that are salpingitis together with the severity distribution in different diagnostic settings and of overlap between routine data sources of PID would be valuable.

Topics

pelvic inflammatory disease incidence england, salpingitis tubal factor infertility risk, recurrent pid fertility outcomes, repeat pelvic infections infertility, pid epidemiology bayesian model, salpingitis ectopic pregnancy risk, tubal inflammation infertility etiology, chronic pid repeat episodes, pelvic infection fallopian tube damage, pid recurrence rate women, salpingitis diagnosis tubal blockage, preventing tubal infertility pid treatment

Cite this article

Price, M., Ades, T., Welton, N. J., Simms, I., & Horner, P. (2016). Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England. *Epidemiology and infection*, *145*(1), 208-215. https://doi.org/10.1017/S0950268816002065

Related articles